With the SpectroPanel tool, Cytek Cloud transforms flow cytometry panel design, enabling rapid optimization and enhancing research capabilities for scientists.
Zenas BioPharma and BMS enter antibody development deal
BMS will obtain exclusive rights for the development and marketing of obexelimab in licensed regions. Credit: Stock-Asso / Shutterstock.com. Zenas BioPharma and Bristol Myers Squibb